Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice

Journal of Clinical Investigation

Volumn 103, Issue 1, 1999, Pages 39-46

  Fern, Robert J ^a   Yesko, Christine M ^a   Thornhill, Barbara A ^a   Kim, Hyung Suk ^b   Smithies, Oliver ^b   Chevalier, Robert L ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; COLLAGEN; DNA; MESSENGER RNA; RENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENOTYPE; KIDNEY DISEASE; KIDNEY FIBROSIS; MICROSCOPY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032919613     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4236     Document Type: Article

References (49)

1. Weber, K.T. 1997. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin. Nephrol. 17:467-491.
2. Noble, N.A., and Border, W.A. 1997. Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin. Nephrol. 17:455-466.
3. Border, W.A., and Noble, N.A. 1998. Interactions of transforming growth factor-beta and angiotensm II in renal fibrosis. Hypertension. 31:181-188.
4. Johnson, R.J., et al. 1992. Renal injury from angiotensin II-mediated hypertension. Hypertension. 19:464-474.
5. Kagami, S., Border, W.A., Miller, D.E., and Noble, N.A. 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-2437.
6. Yoo, K.H., Thornhill, B.A., Wolstenholme, J.T., and Chevalier, R.L. 1998. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am. J. Hypertens. 11:715-722.
7. Anderson, S., Meyer, T.W., Rennke, H.G., and Brenner, B.M. 1985. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 76:612-619.
8. Kohno, M., et al. 1992. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 42:860-866.
9. Chung, K.H., Gomez, R.A., and Chevalier, R.L. 1995. Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction. Am. J. Physiol. 268:F1117-F1123.
10. Chevalier, R.L., Goyal, S., Wolstenholme, J.T., and Thornhill, B.A. 1998. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney Int. 54:38-47.
11. Klahr, S., and Morrissey, J. 1998. Angiotensin II and gene expression in the kidney. Am. J. Kidney Dis. 31:171-176.
12. Smithies, O., and Kim, H.S. 1994. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc. Natl. Acad. Sci. USA 91:3612-3615.
13. Kim, H.S., et al. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
14. Najanan, J.S., et al. 1993. Renal transplantation in the first five years of life. Kidney Int. Suppl. 43:S40-S44.
15. Moller, J.C., Skriver, E., Olsen, S., and Maunsbach, A.B. 1984. Ultrastructural analysis of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch [A]. 402:209-237.
16. Gomez, R.A., et al. 1989. Distribution of renin mRNA and its protein in the developing kidney. Am. J. Physiol. 257:F850-F858.
17. Yosipiv, I.V., and el-Dahr, S.S. 1996. Activation of angiotensin-generating systems in the developing rat kidney. Hypertension. 27:281-286.
18. el-Dahr, S.S., et al. 1990. In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am. J. Physiol. 258:F854-F862.
19. Norwood, V.F., et al. 1994. Neonatal uteteral obstruction stimulates recruitment of renin-secreting renal cortical cells. Kidney Int. 45:1333-1339.
20. el-Dahr, S.S., et al. 1993. Upregulation of renin-angiotensin system and down regulation of kallikrein in obstructive nephropathy. Am. J. Physiol. 264:F874-F881.
21. Yoo, K.H., Norwood, V.F., el-Dahr, S.S., Yosipiv, I., and Chevalier, R.L. 1997. Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction. Am. J. Physiol. 273:R503-R509.
22. Ishidoya, S., Morrissey, J., McCracken, R., Reyes, A., and Klahr, S. 1995. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47:1285-1294.
23. Sheehan, D.C., and Hrapchak, B.B. 1980. Theory and practice of histotechnology. Barelle. Columbus, OH. 188-194.
24. Krege, J.H., Hodgin, J.B., Hagaman, J.R., and Smithies, O. 1995. A non-invasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 25:1111-1115.
25. Lindsey, J., Kim, H.S., Smithies, O., and Gomez, R.A. 1998. Angiotensinogen is necessary for postnatal kidney development. Pediatr. Res. 43:310a. (Abstr.)
26. Niimura, F., et al. 1995. Gene targeting in mice reveals a requirement for angiotensin in ehe development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96:2947-2954.
27. Risdon, R.A., Sloper, J.C., and De, W.E. 1968. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 2:363-366.
28. Schainuck, L.I., Striker, G.E., Cutler, R.E., and Benditt, E.P. 1970. Structural-functional correlations in renal disease. II. The correlations. Hum. Pathol. 1:631-641.
29. Ishidoya, S., Morrissey, J., McCracken, R., and Klahr, S. 1996. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int. 49:1110-1119.
30. Van Zoelen, E.J., et al. 1994. Bradykinin-induced growth inhibition of normal rat kidney (NRK) cells is paralleled by a decrease in epidermal-growth-factor receptor expression. Biochem. J. 298:335-340.
31. Gesualdo, L., et al. 1997. Angiotensin IV, inducing plasminogen activator inhibitor 1 (PAI-1) expression in proximal tubular epithelial cells, may be implicated in the pathogenesis of renal interstitial fibrosis. J. Am. Soc. Nephrol. 8:515a. (Abstr.)
32. Von Thun, A.M., Van, R.C., el-Dahr, S.S., and Navar, L.G. 1994. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am. J. Physiol. 266:F120-F128.
33. Ibrahim, H.N., Rosenberg, M.E., and Hostetter, T.H. 1997. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Semin. Nephrol. 17:431-440.
34. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B., and Ruoslahti, E. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 346:371-374.
35. Border, W.A., et al. 1992. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 360:361-364.
36. Sharma, K., Jin, Y., Guo, J., and Ziyadeh, F.N. 1996. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes. 45:522-530.
37. Isaka, Y., et al. 1993. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92:2597-2601.
38. Kopp, J.B., et al. 1996. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab. Invest. 74:991-1003.
39. Greene, E.L., Kren, S., and Hostetter, T.H. 1996. Role of aldosterone in the remnant kidney model in the rat. J. Clin. Invest. 98:1063-1068.
40. Eddy, A.A. 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7:2495-2508.
41. Chevalier, R.L. 1996. Growth factors andapoptosis in neonatal ureteral obstruction. J. Am. Soc. Nephrol. 7:1098-1105.
42. Lais, L.T., Rios, L.L., Boutelle, S., DiBona, G.F., and Brody, M.J. 1977. Arterial pressure development in neonatal and young spontaneously hypertensive rats. Blood Vessels. 14:227-284.
43. Gray, S.D. 1984. Spontaneous hypertension in the neonatal rat: a review. Clin. Exp. Hypertens. 6:755-781.
44. Josephson, S., and Hemsen, A. 1994. Renal tissue endothelin in long-term complete ureteric obstruction in the young rat. Urol. Int. 53:57-61.
45. Miyazaki, Y., et al. 1998. A new role for mammalian angiotensin: adapting the kidney to extrauterine life. Pediatr. Res. 43:311a. (Abstr.)
46. Wolf, G. and Neilson, E.G. 1990. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol. 259:F768-F777.
47. Tufro-McReddie, A., Romano, L.M., Harris, J.M., Ferder, L., and Gomez, R.A. 1995. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 269:F110-F115.
48. Dworkin, L.D., Grosser, M., Feiner, H.D., Ullian, M., and Parker, M. 1989. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int. 35:790-798.
49. Valentin, J.P., Sechi, L.A., Griffin, C.A., Humphreys, M.H., and Schambelan, M. 1997. The renin-angiotensin system and compensatory renal hypertrophy in the rat. Am. J. Hypertens. 10:397-402.